Most Recent
International law firm Dentons has lured the principal of IPH Limited, which owns leading intellectual property firms including Griffith Hack and Spruson & Ferguson, for its Australasian patents team.
A judge has found Shenzhen-based based radio manufacturer Hytera engaged in "substantial industrial theft" by appropriating Motorola's source code for its digital mobile radios and should be on the hook for additional damages for "flagrantly" infringing Motorola's copyright.
Mastercard has lost a bid to patent a data processing system used to prevent fraud on payment card networks, with an IP delegate Australia ruling the invention “does not rise above an idea.”
Trial in the battle of the buns has begun, with McDonald's laying out a case for why its rival's Big Jack burger infringes its trade mark, and Hungry Jack's firing back that consumers could not confuse its flame-grilled meal with the iconic Big Mac.
Media company The Economist has failed in its opposition to registration of a trade mark for The Beer Economist, with an IP Australia delegate saying the mark was not substantially identical or deceptively similar to the UK publisher's brand.
Cable TV giant Foxtel has lost a protracted IP battle with subsidiary of global tech giant Cognizant over a digital download patent for a modern DVR system.
IP Australia has rejected the patent application of Scandinavian dairy giant Arla Foods amba, finding its high-protein whey-based yoghurt invention lacked an inventive step.
Explosives manufacturer Orica is closer to taking Dyno Nobel to court for allegedly infringing three of its explosives patents, filing proceedings to get more information about its rival's CyberDet wireless detonator device.
Agricultural chemical company Nufarm has appealed a decision giving rival Advanta Seeds extra time to pay a renewal fee for its patent for a hybrid plant cell after correspondence from its lawyers was sent to employees that had left the company and the patent renewal fell through the cracks.
The Full Federal Court has rejected German drug maker Boehringer Ingelheim's appeal of ruling that shot down its opposition to Merck Sharp & Dohme's patent application for an injectable anti-parasite drug for livestock.